Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 358.19M P/E - EPS this Y -19.50% Ern Qtrly Grth -
Income -84.03M Forward P/E -3.31 EPS next Y 183.10% 50D Avg Chg -13.00%
Sales 14.02M PEG -1.14 EPS past 5Y - 200D Avg Chg -10.00%
Dividend N/A Price/Book 3.25 EPS next 5Y 2.40% 52W High Chg -48.00%
Recommedations 1.80 Quick Ratio 2.28 Shares Outstanding 64.31M 52W Low Chg 26.00%
Insider Own 17.32% ROA -26.56% Shares Float 25.77M Beta 1.27
Inst Own 61.80% ROE -65.67% Shares Shorted/Prior 1.14M/1.25M Price 6.02
Gross Margin 100.00% Profit Margin - Avg. Volume 139,854 Target Price 21.60
Oper. Margin -2,144.80% Earnings Date May 9 Volume 67,695 Change -0.82%
About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.

MeiraGTx Holdings plc News
04/25/24 MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?
04/24/24 MeiraGTx to Participate in Upcoming Investor Conferences
04/18/24 MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
03/14/24 MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023
03/14/24 MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates
03/14/24 MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
02/26/24 MeiraGTx Holdings plc (NASDAQ:MGTX) stock most popular amongst private equity firms who own 28%, while individual investors hold 26%
02/13/24 MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
02/06/24 Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?
01/10/24 Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet
01/10/24 MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions
01/02/24 MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
12/25/23 Wall Street Analysts Believe MeiraGTx Holdings PLC (MGTX) Could Rally 221.78%: Here's is How to Trade
12/21/23 J&J bets bigger on MeiraGTx’s eye gene therapy
12/21/23 MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
12/14/23 The past three years for MeiraGTx Holdings (NASDAQ:MGTX) investors has not been profitable
11/14/23 MeiraGTx Holdings PLC Reports Q3 2023 Financial Results and Operational Progress
11/14/23 MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
10/30/23 Sanofi invests in MeiraGTx and its gene-regulating technology
10/30/23 MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities
MGTX Chatroom

User Image Cinderblocks Posted - 2 days ago

$MGTX Big orders coming through the last 5 days. People sleeping on this. Buyout candidate. I will keep buying.

User Image waterlock Posted - 04/25/24

$MGTX Shareholders should vote Against to all the resolutions. Forbes has done a terrible job. She failed to demonstrate a great product. She should resign.

User Image Stock_Titan Posted - 04/24/24

$MGTX MeiraGTx to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/MGTX/meira-g-tx-to-participate-in-upcoming-investor-8yvu1ulnk6hr.html

User Image waterlock Posted - 04/22/24

$MGTX interesting. I think there was a block trade that just happened with 300 K USD

User Image Stock_Titan Posted - 04/18/24

$MGTX MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference https://www.stocktitan.net/news/MGTX/meira-g-tx-announces-oral-presentation-at-the-2024-american-academy-b8h7fts4fpmr.html

User Image MacSweeney Posted - 04/18/24

$MGTX New position $5.09

User Image Cinderblocks Posted - 04/18/24

$MGTX I averaged down here.

User Image Cinderblocks Posted - 04/09/24

$MGTX Whenever it drops to 5.5 range, volume comes in and big orders go through. I think this is a very good stock to hold. Buyout candidate.

User Image waterlock Posted - 1 month ago

TOP 3 $MGTX $SANA $WVE typo

User Image waterlock Posted - 1 month ago

$KALV WTF?!!? I did not notice this. They have closed 150M USD at ~$15. I thought their stock price went to so did not completed he fundraising. Well, now it is a huge buy for me. ================= Also in February, KalVista closed an underwritten offering to sell an aggregate of 7,016,312 shares of common stock at price of $15.25 per share and pre-funded warrants to purchase up to 3,483,688 shares of common stock at a price of $15.249 per pre-funded warrant. Top 3 holding: $MGTX $SANA $KALV

User Image waterlock Posted - 1 month ago

$MGTX always a buy under 6

User Image Cinderblocks Posted - 1 month ago

$MGTX Waiting to get bought out.

User Image valueforme Posted - 03/20/24

$MGTX https://www.biotechtv.com/post/meiragtx-march-19-2024

User Image myshtigo Posted - 03/17/24

$MGTX ok

User Image Fullratio Posted - 03/16/24

$MGTX quick ratio has soared by 53% from the previous quarter and by 26% YoY: https://fullratio.com/stocks/nasdaq-mgtx/meiragtx-holdings

User Image Stock_Titan Posted - 03/14/24

$MGTX MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates https://www.stocktitan.net/news/MGTX/meira-g-tx-reports-fourth-quarter-and-full-year-2023-financial-and-fi5s26mkme7e.html

User Image transfercoefficient Posted - 03/13/24

$MGTX We need to get some activity on this board.

User Image transfercoefficient Posted - 03/07/24

$MGTX

User Image valueforme Posted - 03/05/24

$MGTX Interesting.

User Image swingingtech Posted - 03/05/24

$PRAX $MGTX https://wallstreetwaves.com/praxis-precision-medicines-inc-prax-reports-q4-loss-tops-revenue-estimates/

User Image waterlock Posted - 02/16/24

$KALV Pople are confused here. Dilution matters only when the offering price is lower than the current stock price. The company has great financial condition. A potential blockbuster drug. My only concern is that their trial recruited 50% mild patients while Firazyr has 100% (moderate+severe). There could be potential label restriction. But still, the mktcap is too low now. Investors include VR Adviser (biggest holding Rayzbio currently acquired), Frazier I'm bullish on this one. Bought some at 14.2. WIll buy more this coming week if price is attractive. $MGTX

User Image Pivot91 Posted - 02/15/24

$MGTX spike coming in weeks time. will go back to previous range. Institional investor have been loading more shares in this downside consolidation. See us above tens.

User Image DonCorleone77 Posted - 02/13/24

$MGTX $JNJ MeiraGTx announces $50M milestone from Janssen Pharmaceuticals MeiraGTx Holdings (MGTX) announced the achievement of the first milestone under the asset purchase agreement the Company entered into with Janssen Pharmaceuticals, a Johnson & Johnson company (JNJ), in December 2023 relating to bota-vec for the treatment of XLRP. "We are very happy to announce that the LUMEOS extension study has been initiated, which triggered the $50 million milestone payment to MeiraGTx under the asset purchase agreement with J&J," said Alexandria Forbes, Ph.D., president and chief executive officer of MeiraGTx. Agreements related to bota-vec: MeiraGTx anticipates receiving an additional $15 million in near-term milestone payments later in 2024; The Company will receive up to a further $285 million upon first commercial sales of bota-vec in the U.S. and EU and for manufacturing technology transfer...

User Image Tommy_Two_Toes Posted - 02/13/24

$MGTX here too. $50 mil from Jansen

User Image momeymaker1 Posted - 02/13/24

$MGTX

User Image TheTradeXchange Posted - 02/13/24

$MGTX - MeiraGTx Announces $50 Million Milestone from Janssen PharmaceuticalsMeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP)

User Image Stock_Titan Posted - 02/13/24

$MGTX MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals https://www.stocktitan.net/news/MGTX/meira-g-tx-announces-50-million-milestone-from-janssen-4ztyfgg7c1l4.html

User Image waterlock Posted - 02/13/24

$MGTX by end of Feb, MGTX will be over 8

User Image Doozio Posted - 02/06/24

$MGNX so scrabble bag it with $mgtx ?

User Image Doozio Posted - 02/06/24

$MGTX MNDY 🐑 low into gap held the 200d. Down ♾️ since a 🧠👀 became 🧠⏰

Analyst Ratings
RBC Capital Outperform Mar 15, 24
RBC Capital Outperform Aug 11, 23
Chardan Capital Buy Aug 11, 23
Piper Sandler Overweight May 12, 23
Chardan Capital Buy Mar 16, 23
RBC Capital Outperform Mar 15, 23
Chardan Capital Buy Aug 12, 22
Chardan Capital Buy May 13, 22
Barclays Overweight May 13, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERCEPTIVE ADVISORS LLC Director Director May 05 Buy 5.75 4,347,826 25,000,000 11,281,103 05/15/23
Zeldin Robert K CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Jun 03 Buy 7.9 5,000 39,500 5,000 06/06/22
Forbes Alexandria President and CEO President and CEO Nov 16 Sell 20.07 30,000 602,100 1,080,781 11/18/21
Giroux Richard CFO & COO CFO & COO Oct 19 Sell 20.76 22,000 456,720 819,218 10/21/21
Forbes Alexandria President and CEO President and CEO Oct 18 Sell 17.57 30,000 527,100 1,110,781 10/20/21